Keyphrases
Multiple Myeloma
100%
Marrow
100%
High-dose Therapy
100%
Allografting
100%
Unrelated Donor
100%
Renal Disease
33%
Graft Failure
33%
Overall Survival
33%
Survivors
33%
Disease Progression
33%
Infection Rate
33%
Myeloma
33%
Living Donor
33%
Graft-versus-host Disease (GvHD)
33%
Young Patients
33%
Disease-free Survival
33%
Early Death
33%
Allogeneic Bone Marrow Transplantation
33%
Hepatic Dysfunction
33%
Matched Sibling
33%
Treatment-related Mortality
33%
Single-center Experience
33%
Haploidentical
33%
Medicine and Dentistry
Drug Megadose
100%
Multiple Myeloma
100%
Disease Free Survival
50%
Overall Survival
50%
Allogenic Bone Marrow Transplantation
50%
Disease Exacerbation
50%
Myeloma
50%
Graft Failure
50%
Liver Dysfunction
50%
Graft Versus Host Reaction
50%
Diseases
50%
Immunology and Microbiology
Drug Megadose
100%
Multiple Myeloma
100%
Graft-Versus-Host Disease
50%
Allogeneic Bone Marrow Transplantation
50%
Overall Survival
50%
Disease Free Survival
50%